Relief Therapeutics Holding AG (RLFTF)

[tcm55]

In the RLF - NRX 50-50% / 80-20% deal the manufacturing and logistics were RLF's responsibilities and running the CTs/FDA, sales and marketing were primarily with NRX. Right?

Splitting markets of course too. Now the world market is looking larger.

IMO, the EUA(s) will be successful pretty FAST for RLF-100*. thru NRX efforts, as that is needed for their NRXP deal.

GEM has financed BOTH paths. They UNDERSTAND MEDIA and liquidity, that's their 'thing'.!.

The FDA does not have many successful Phase 3 COVID Trial EUA Applications to consider. ONLY ONE I THINK.

...GLTA...






*whatever BRAND name for a formulation of Patented RLF-100...